CGRP Education & Research Forum
Already a member? Become a member Register
youtubeLinkedIn
Latest:

Videos

Expert views and opinion

International experts discuss hot topics in the prevention of migraine in patients worldwide.

PlayIn the Middle East, how common is migraine and what medicines are used?
In the Middle East, how common is migraine and what medicines are used?
PlayWhat are the main treatment problems and how can these be addressed?
What are the main treatment problems and how can these be addressed?
Playما مدى انتشار الصداع النصفي (الشقيقة) في الشرق الأوسط وما هي الأدوية المستخدمة؟
ما مدى انتشار الصداع النصفي (الشقيقة) في الشرق الأوسط وما هي الأدوية المستخدمة؟
Playما هي المشاكل الرئيسية في العلاج وكيف يمكن التعامل معها؟
ما هي المشاكل الرئيسية في العلاج وكيف يمكن التعامل معها؟
PlayWhat advice would you give clinicians about how patients can obtain reimbursement for anti-CGRP therapies?
What advice would you give clinicians about how patients can obtain reimbursement for anti-CGRP therapies?
PlayQue conselhos daria aos médicos para ajudar os pacientes a obter o reembolso de terapias anti-CGRP?
Que conselhos daria aos médicos para ajudar os pacientes a obter o reembolso de terapias anti-CGRP?
PlayO que os médicos devem saber sobre a combinação de terapias anti-CGRP com outros tratamentos para a migrânea?
O que os médicos devem saber sobre a combinação de terapias anti-CGRP com outros tratamentos para a migrânea?
PlayWhat should clinicians know about combining anti-CGRP therapies with other migraine treatments?
What should clinicians know about combining anti-CGRP therapies with other migraine treatments?
PlayQuais pacientes podem se beneficiar das terapias anti-CGRP e como é o acompanhamento de terapias anti-CGRP?
Quais pacientes podem se beneficiar das terapias anti-CGRP e como é o acompanhamento de terapias anti-CGRP?
PlayWhich patients in Brazil are suitable for anti-CGRP therapies and how do you follow up people on anti-CGRP therapies?
Which patients in Brazil are suitable for anti-CGRP therapies and how do you follow up people on anti-CGRP therapies?
PlayQuão boas são as evidências apoiando as terapias anti-CGRP?
Quão boas são as evidências apoiando as terapias anti-CGRP?
PlayQuais são os principais problemas enfrentados pelos médicos que tratam a migrânea no Brasil?
Quais são os principais problemas enfrentados pelos médicos que tratam a migrânea no Brasil?
PlayQuão comum é a migrânea no Brasil e como ela é tratada
Quão comum é a migrânea no Brasil e como ela é tratada
PlayHow good is the evidence supporting anti-CGRP therapies?
How good is the evidence supporting anti-CGRP therapies?
PlayWhat are the main problems for doctors treating migraine in Brazil?
What are the main problems for doctors treating migraine in Brazil?
PlayHow common is migraine in Brazil and how is it treated?
How common is migraine in Brazil and how is it treated?
PlayCombining CGRP mAbs and gepants: what do we know?
Combining CGRP mAbs and gepants: what do we know?
Play2020 brought new hope for patients with migraine – how will 2021 build on this success?
2020 brought new hope for patients with migraine – how will 2021 build on this success?
PlayAnti-CGRP therapies – what did we learn in 2020 and what can we expect in 2021?
Anti-CGRP therapies – what did we learn in 2020 and what can we expect in 2021?
PlayMigraine: a new treatment landscape
Migraine: a new treatment landscape
PlayCGRP in cluster headache
CGRP in cluster headache
PlayCGRP therapies in acute migraine
CGRP therapies in acute migraine
PlayWhat next for anti-CGRP therapy?
What next for anti-CGRP therapy?
PlayBecome a member of CGRP Forum
Become a member of CGRP Forum
PlayWhy is CGRP an important therapeutic target?
Why is CGRP an important therapeutic target?

The opinions and statements made in videos and interviews are those of the contributors. The grantors, editors, editorial board or Secretariat do not necessarily share the views expressed. No liability on the part of the grantors, editors, editorial board or Secretariat is accepted for the consequences of any misleading or inaccurate information.